| Name | Title | Contact Details |
|---|---|---|
Cameron Lazek |
VP, Total Rewards, People Ops, Analytics & Systems | Profile |
Steven Pitts |
Vice President of Content Production, Technology and Operations | Profile |
Ariel Dos Santos |
Vice President of Technology | Profile |
Shobhana Ahluwalia |
Chief Information Officer | Profile |
Adrian Stone |
Vice President Information Security and CISO | Profile |
Medical Resources is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Southwest Medical Imaging Limited is a radiology practice that operates 17 imaging centers in Phoenix, Arizona. They offer a range of diagnostic medical imaging services, including MRI, CT, PET CT, Mammography & Breast Services, Ultrasound, DEXA, X ray...
Impact Cryotherapy is the national leader in designing and manufacturing whole body cryotherapy systems. The company`s state-of-the-art cryosaunas are sleek, attractive single-person chambers that are engineered and manufactured in the United States in an ISO 9001 certified facility. Impact Cryotherapy is redefining the age-old technique of cryotherapy with advanced technology and aesthetics to deliver unmatched efficiency, comfort and reliability.
TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.
abeo is a nationwide medical billing and software company focused on delivering revenue-enhancing services to private practices, hospitals and surgery centers. We bridge the gap between the constant change in healthcare and your changing needs as a result. We know the healthcare landscape; we know the complexities and regulations. Our professional management services, medical billing software and anesthesia advisory services are tailored to improve the operational and financial performance for the specialty of anesthesiology. We blend our employee expertise in anesthesia with process and technology to take efficiency to the next level. Operational best practices play a key role in our ability to provide the quality of service clients receive and have come to expect from abeo. Our clients know their best interest is at the center of abeo doing their job, and doing it well.